EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

Mengqian Li, Yijin Yu iD, Guangyue Liu, Shunhong Zhang, Chenchen Luo, Saidi Hu, Siran Wan, Linyong Zhao iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35523 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Mengqian Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: RNA, Messenger, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs. As techniques that have enabled us to analyze transcriptome profiling become ever more sophisticated, the great potential of extracellular messenger RNA (mRNA) and intracellular (cellular level) mRNA in liquid biopsy has gradually been realized. In this review, we aim to conclude the mRNA‐based liquid biopsy in the tumorous context by illustrating the origins of mRNA markers and scientific findings, and summarizing the advantages of mRNAs over DNA‐based liquid biopsy. Besides, we give a glimpse of the application of this strategy in clinical studies and analyze the gap between the bench and bedside. We speculate that mRNAs are a promising frontier of liquid biopsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerNeoplasmsBiomarkers, TumorHumansLiquid BiopsyGene Expression ProfilingCell-Free Nucleic Acids

Stichwörter der Autor:innen

cell‐free RNAcirculating tumor cellextracellular vesicleliquid biopsymessenger RNA

Substanzen

RNA, MessengerBiomarkers, TumorCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of General Surgery & Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
  • The 19th Batch of Chinese Medical Team in Sao Tome and Principe, China.
  • Department of Cardiology, Panzhihua Iron and Steel Group General Hospital, Panzhihua, China.

ORCID-Profile: Yijin Yu, Linyong Zhao

Förderung

  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Li, M., Yu, Y., Liu, G., Zhang, S., Luo, C., Hu, S., Wan, S., & Zhao, L. (2025). A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications. International Journal of Cancer. https://doi.org/10.1002/ijc.35523

Vancouver

Li M, Yu Y, Liu G, Zhang S, Luo C, Hu S, et al. A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications. International Journal of Cancer. 2025. doi:10.1002/ijc.35523

BibTeX
@article{Li2025,
  author = {Li, Mengqian and Yu, Yijin and Liu, Guangyue and Zhang, Shunhong and Luo, Chenchen and Hu, Saidi and Wan, Siran and Zhao, Linyong},
  title = {A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35523}
}
Kostenlos starten →